phasePhase II data read out end of H2 2024 - should that data packet substantiate and demonstrate improved statistical significance in line with the previous stage 2 study results then there is every possibility this product gets acquired on the strength of that outcome -
especially with this guy doing the inside work on 42X\
https://finance.yahoo.com/news/incannex-appoints-fda-regulatory-affairs-120000576.html![]()
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-19866
-
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)